<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33473">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01915719</url>
  </required_header>
  <id_info>
    <org_study_id>IVNICTUS</org_study_id>
    <nct_id>NCT01915719</nct_id>
  </id_info>
  <brief_title>Early Non Invasive Ventilation in Immuno-compromized Patients With Acute Respiratory Failure.</brief_title>
  <acronym>IVNICTUS</acronym>
  <official_title>Early Non Invasive Ventilation in Immuno-compromized Patients With Acute Respiratory Failure. A Prospective Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <authority>France: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assess the superiority of early non invasive ventilation in comparison to Oxygen therapy
      only, for immuno-compromized  patients with acute respiratory failure
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Day 28 Mortality</measure>
    <time_frame>Day 28</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Needs of mechanical ventilation</measure>
    <time_frame>Day 28</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA Score</measure>
    <time_frame>Hour 72</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nosocomial infection</measure>
    <time_frame>day 28</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in ICU</measure>
    <time_frame>Day 28</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>performance status (OMS scale ranging from 0-perfect status- to 4-moribund)</measure>
    <time_frame>6 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">374</enrollment>
  <condition>Adult</condition>
  <condition>Acute Respiratory Failure Admitted in ICU</condition>
  <condition>Immuno Compromized</condition>
  <arm_group>
    <arm_group_label>Early non invasive ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Early non invasive ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxygen therapy only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oxygen therapy only</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early non invasive ventilation</intervention_name>
    <arm_group_label>Early non invasive ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oxygen therapy only</intervention_name>
    <arm_group_label>Oxygen therapy only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years old

          -  ICU admission

          -  Acute respiratory failure defined by (PaO2&lt;60 mmHg at room air) or (polypnea  &gt;30/min
             or dyspnea at rest) or respiratory distress. Since less than 72 hours.

          -  Immuno compromized patient defined by solid tumor (treated since less than 5 years)
             or haematological malignancy (treated since less than 5 years) or Solid organ
             transplantation or Stem cell transplantation or Immunosuppressive treatment (steroid
             &gt; 1mg/kg/d or &gt;1 month or other immunosuppressive treatment &gt;1 month)

        Exclusion Criteria:

          -  Hypercapnia &gt;50 mmHg or increased of hypercapnia &gt;10 mmHg under Oxygen treatment

          -  Need of immediate mechanical ventilation

          -  Obvious cardiogenic oedema

          -  Vasopressor use &gt;0.03 µg/kg/min

          -  Glasgow Score &lt;13

          -  End of life decision

          -  Acute myocardial infarction

          -  Patient refusal

          -  Pregnancy

          -  No national health insurance
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Virginie lemiale, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Virgine Lemiale, MD</last_name>
    <phone>+33 142499419</phone>
    <email>virginie.lemiale@sls.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>APHP, Hôpital Saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>virginie lemiale, MD</last_name>
      <phone>+33 142499419</phone>
      <email>virginie.lemiale@sls.aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 22, 2014</lastchanged_date>
  <firstreceived_date>July 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
